tenofovir has been researched along with Bone Fractures in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 12 (54.55) | 24.3611 |
| 2020's | 6 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, AL; Alexeeff, S; Hechter, RC; Horberg, MA; Hu, H; Lam, JO; Lea, A; Leyden, WA; Lo, JC; Marcus, JL; Pak, KJ; Rivera, AS; Silverberg, MJ; Towner, WJ; Yuan, Q; Zhou, H | 1 |
| Arpadi, SM; Shiau, S; Yin, MT | 1 |
| Freedberg, KA; Horn, T; McCann, NC; Paltiel, AD; Walensky, RP | 1 |
| Adams-Huet, B; Bedimo, RJ; Maalouf, NM; Moore-Matthews, D; Nguyen, V; Poindexter, J | 1 |
| Alvarez-Barco, E; Mallon, PWG | 1 |
| Chipanga, J; Ferrand, RA; Filteau, S; Gregson, CL; Kowo-Nyakoko, F; Madanhire, T; McHugh, G; Mujuru, H; Mukwasi-Kahari, C; Rehman, AM; Rukuni, R; Simms, V; Ward, KA | 1 |
| Borges, ÁH; Flamholc, L; Florence, E; Gargalianos-Kakolyris, P; Hoy, J; Kyselyova, G; Leen, C; Lundgren, JD; Maltez, F; Mocroft, A; Mulcahy, F; Orkin, C; Pedersen, C; Pradier, C; Ridolfo, AL; Schmid, P; Sedlacek, D; Staub, T; Stellbrink, HJ; Tomazic, J; Uzdaviniene, V; Weber, R | 1 |
| Adams-Huet, B; Bedimo, RJ; Brown, G; Castanon, R; Farukhi, I; Maalouf, NM; Moore, T; Poindexter, J; Tebas, P; Turner, D | 1 |
| Ikeda, A; Kikuchi, A; Komatsu, A; Matsushita, S; Minami, C; Tan, M | 1 |
| Abgrall, S; Costagliola, D; Duvivier, C; Fischer, H; Joly, V; Lacombe, JM; Lang, S; Mary-Krause, M; Potard, V; Rozenberg, S; Valantin, MA | 1 |
| Althoff, KN; Brown, TT; Estrella, MM; Gonciulea, A; Kingsley, LA; Lake, JE; Palella, FJ; Sellmeyer, DE; Wang, R | 1 |
| Carr, A; Ebeling, P; Hoy, J; Kerr, SJ; Martinez, E; Pocock, N; Richardson, R; Rojas, J | 1 |
| Cotter, AG; Grant, PM | 1 |
| Briel, M; Bucher, HC; Bühler, JE; Ewald, H; Hemkens, LG; Santini-Oliveira, M; Schandelmaier, S; Stöckle, M; Vuichard, D | 1 |
| Aslangul, E; Caillat-Vigneron, N; Le Jeunne, C; Perrot, S; Szwebel, T | 1 |
| Collier, AC; Daar, ES; Farajallah, A; Fischl, MA; Geiseler, PJ; Godfrey, C; Ha, B; Jahed, NC; Johnson, VA; Katzenstein, D; Koletar, SL; Mollan, K; Myers, L; Peeples, L; Rooney, JF; Sax, PE; Tierney, C; Woodward, WC | 1 |
| Carr, A; Hoy, J | 1 |
| Daar, ES; Ha, B; Jahed, NC; Kitch, D; McComsey, GA; Melbourne, K; Myers, L; Sax, PE; Tebas, P; Tierney, C | 1 |
| Buchbinder, SP; Chillag, K; Grant, R; Grohskopf, L; Gvetadze, R; Irvin, R; Liu, AY; Mayer, K; Mulligan, K; O'Hara, B; Pathak, S; Sellmeyer, DE; Thompson, M; Vittinghoff, E | 1 |
| Chidziva, E; Gibb, DM; Gilks, CF; Grosskurth, H; Hakim, J; Kizito, H; Kyomugisha, H; Munderi, P; Musoke, P; Nalumenya, R; Nathoo, K; Russell, EC; Spyer, M; Tumukunde, D; Walker, AS; Zalwango, E | 1 |
| Cabau, J; Gort, A; Planella, R; Roselló, L | 1 |
4 review(s) available for tenofovir and Bone Fractures
| Article | Year |
|---|---|
Bone Update: Is It Still an Issue Without Tenofovir Disoproxil Fumarate?
Topics: Adolescent; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Bone and Bones; Bone Density; Child; Female; Fractures, Bone; HIV Infections; Humans; Osteoporosis; Risk Factors; Tenofovir | 2020 |
What's new in bone disease and fractures in HIV?
Topics: Anti-HIV Agents; Bone Density; Bone Diseases, Metabolic; Fractures, Bone; HIV Infections; Humans; Tenofovir | 2021 |
Tenofovir and bone health.
Topics: Anti-HIV Agents; Bone Diseases, Metabolic; Fractures, Bone; HIV Infections; Humans; Tenofovir | 2016 |
Comparative effectiveness of tenofovir in HIV-infected treatment-experienced patients: systematic review and meta-analysis.
Topics: Antiretroviral Therapy, Highly Active; Biomarkers; Bone Density; CD4 Lymphocyte Count; Fractures, Bone; HIV Infections; Humans; Lipid Metabolism; Lipids; Publication Bias; Randomized Controlled Trials as Topic; Retreatment; Reverse Transcriptase Inhibitors; Tenofovir; Treatment Failure; Treatment Outcome; Viral Load | 2017 |
5 trial(s) available for tenofovir and Bone Fractures
| Article | Year |
|---|---|
Prolonged Effect of Zoledronic Acid on Bone Mineral Density and Turnover in HIV-Infected Adults on Tenofovir: A Randomized, Open-Label Study.
Topics: Adult; Biomarkers; Bone Density; Bone Remodeling; Female; Fractures, Bone; HIV Infections; Humans; Male; Middle Aged; Tenofovir; Treatment Outcome; Zoledronic Acid | 2019 |
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.
Topics: Adenine; Adolescent; Adult; Analysis of Variance; Anti-HIV Agents; CD4 Lymphocyte Count; Deoxycytidine; Dideoxynucleosides; Double-Blind Method; Drug Combinations; Drug Resistance, Viral; Emtricitabine; Female; Fractures, Bone; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; RNA, Viral; Tenofovir; Therapeutic Equivalency; Time Factors; Treatment Failure; Viral Load; Young Adult | 2009 |
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG
Topics: Absorptiometry, Photon; Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Benzoxazines; Bone Density; CD4 Lymphocyte Count; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Drug Therapy, Combination; Emtricitabine; Female; Fractures, Bone; HIV Infections; Humans; Intention to Treat Analysis; Lamivudine; Male; Middle Aged; Oligopeptides; Organophosphonates; Osteoporosis; Pyridines; Risk Factors; Ritonavir; Tenofovir; Viral Load | 2011 |
Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco.
Topics: Absorptiometry, Photon; Adenine; Adolescent; Adult; Anti-HIV Agents; Bone Density; Eligibility Determination; Fractures, Bone; HIV Seronegativity; Homosexuality, Male; Humans; Longitudinal Studies; Male; Middle Aged; Organophosphonates; Preventive Health Services; San Francisco; Tenofovir; Young Adult | 2011 |
Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.
Topics: Abortion, Spontaneous; Adenine; Adult; Anti-HIV Agents; Body Height; Body Weight; Breast Feeding; Burns; Cause of Death; Child, Preschool; Congenital Abnormalities; Drug Combinations; Female; Follow-Up Studies; Fractures, Bone; Growth; HIV Infections; HIV Seropositivity; Humans; Infant; Infant Mortality; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Male; Measles; Organophosphonates; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Prevalence; Respiratory Tract Infections; Tenofovir; Uganda; Zidovudine; Zimbabwe | 2012 |
13 other study(ies) available for tenofovir and Bone Fractures
| Article | Year |
|---|---|
Fracture Risk and Association With TDF Use Among People With HIV in Large Integrated Health Systems.
Topics: Adult; Anti-HIV Agents; Cohort Studies; Fractures, Bone; HIV Infections; Humans; Middle Aged; Retrospective Studies; Tenofovir | 2023 |
Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis.
Topics: Adenine; Adolescent; Adult; Anti-HIV Agents; Cost-Benefit Analysis; Drugs, Generic; Emtricitabine; Fractures, Bone; HIV Infections; Homosexuality, Male; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pre-Exposure Prophylaxis; Quality-Adjusted Life Years; Tenofovir; United States; Young Adult | 2020 |
Changes in bone microarchitecture with abacavir--lamivudine versus tenofovir disoproxil fumarate--emtricitabine in adults living with HIV.
Topics: Absorptiometry, Photon; Adult; Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Emtricitabine; Fractures, Bone; HIV Infections; Humans; Incidence; Lamivudine; Osteoporotic Fractures; Tenofovir | 2020 |
Effect of HIV infection on growth and bone density in peripubertal children in the era of antiretroviral therapy: a cross-sectional study in Zimbabwe.
Topics: Absorptiometry, Photon; Adolescent; Anti-Retroviral Agents; Bone Density; Child; Cross-Sectional Studies; Female; Fractures, Bone; HIV Infections; Humans; Male; Puberty; Tenofovir; Zimbabwe | 2021 |
Antiretrovirals, Fractures, and Osteonecrosis in a Large International HIV Cohort.
Topics: Adult; Anti-HIV Agents; Bone Density; CD4 Lymphocyte Count; Cohort Studies; Coinfection; Data Collection; Europe; Female; Femoral Fractures; Fractures, Bone; HIV Infections; Humans; Male; Middle Aged; Osteonecrosis; Regression Analysis; Risk Factors; Tenofovir | 2017 |
The Differential Effects of Human Immunodeficiency Virus and Hepatitis C Virus on Bone Microarchitecture and Fracture Risk.
Topics: Bone Density; Cancellous Bone; Coinfection; Cross-Sectional Studies; Fractures, Bone; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Male; Middle Aged; Osteoporosis; Prospective Studies; Risk Factors; Tenofovir | 2018 |
Osteoporosis-Related Fractures in HIV-Infected Patients Receiving Long-Term Tenofovir Disoproxil Fumarate: An Observational Cohort Study.
Topics: Adult; Aged; Anti-HIV Agents; Cohort Studies; Drug Administration Schedule; Female; Fractures, Bone; HIV Infections; Humans; Japan; Longitudinal Studies; Male; Middle Aged; Osteoporosis; Tenofovir | 2018 |
Impact of Antiretroviral Drugs on Fracture Risk in HIV-Infected Individuals: A Case-Control Study Nested Within the French Hospital Database on HIV (FHDH-ANRS CO4).
Topics: Adult; Anti-Retroviral Agents; Case-Control Studies; Databases, Factual; Female; Fractures, Bone; France; HIV Infections; HIV Protease Inhibitors; Humans; Incidence; Male; Middle Aged; Odds Ratio; Tenofovir | 2019 |
Proteinuria Is Associated With Increased Risk of Fragility Fracture in Men With or at Risk of HIV Infection.
Topics: Adult; Anti-HIV Agents; Fractures, Bone; HIV Infections; Homosexuality, Male; Humans; Male; Middle Aged; Prevalence; Proportional Hazards Models; Prospective Studies; Proteinuria; Risk Factors; Tenofovir | 2019 |
Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient.
Topics: Adenine; Bone Density Conservation Agents; Fanconi Syndrome; Female; Fractures, Bone; HIV Infections; Humans; Middle Aged; Organophosphonates; Osteomalacia; Pain; Reverse Transcriptase Inhibitors; Tenofovir | 2009 |
Tenofovir: new indication. In chronic hepatitis B: beware bone toxicity.
Topics: Adenine; Antiviral Agents; Bone and Bones; Bone Diseases; Double-Blind Method; Drug Approval; Europe; Fractures, Bone; Hepatitis B, Chronic; Humans; Organophosphonates; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tenofovir; Viremia; Virus Replication | 2009 |
Low bone mineral density with tenofovir: does statistically significant mean clinically significant?
Topics: Adenine; Adult; Anti-HIV Agents; Bone Density; Bone Diseases; Female; Fractures, Bone; HIV Infections; Humans; Incidence; Male; Organophosphonates; Tenofovir | 2010 |
[Hypophosphatemia and multiple fractures in patient with human immunodeficiency virus infection treated with tenofovir].
Topics: Adenine; Adult; Fractures, Bone; HIV Infections; Humans; Hypophosphatemia; Male; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir | 2007 |